Nidan, McMagyar, et al perhaps the FDA is slowly implementing the new guidences to give the behemoth BP's more time to "bow out" gracefully in the face of shareholders. Also a way of helping to soften negative public perception as this monumental change is ushered in. Easy for us to use terms like paradigm shift, precision medicine, cutting edge adaptive trial designs on a message board but for these massive floating "lame duck divisions" who have been sitting in Board rooms for decades answering (ehhummm.... boolshetting shareholders) to investors.....its not so easy. Look no further that the last 6 months of companies cutting ties with failed drug trials, and Pfizer's complete about face with its own Neuro division.
The big (and small ships like AXON) ships are slowly sinking or turning back and as we look around we are slowly becoming one of the few small ships left in a race for an answer to the horrible symptoms for many horrible diseases, not just ALZ.
Take your time Missling! Get it right and lets sturdy up the "poison pill" protections while we are at it. In fact if the read outs for Rett Syndrome happen to come AFTER our AGM, that might be convenient.
#Big changes ahead!
Tred
News 
Market Data 
Discover 
AI
